Table 6. Co-expression of bcl-2 and c-myc in the control and study groups.

bcl-2 and c-myc co-expression	Control group, n (%)	Low grade SIL, n (%)	High grade SIL, n (%)	PVU in situ carcinoma, n (%)	PVU invasive carcinoma, n (%)
Negative (−)	28/36 (77.8)	24/32 (75)	16/22 (72.8)	18/22 (81.9)	12/26 (46.2)
Negative (1+)	8/36 (22.2)	8/32 (25.0)	6/22 (27.2)	4/22 (18.1)	8/26 (30.8)
Positive (2+)	0/36 (0)	0/32 (0)	0/22 (0)	0/22 (0)	2/26 (7.7)
Positive (3+)	0/36 (0)	0/32 (0)	0/22 (0)	0/22 (0)	4/26 (15.3)

SIL, squamous intraepithelial lesions; PVU, portio vaginalis uteri.